2022 - Canadian IP Year in Review

People

Smart & Biggar is Canada’s largest and highest ranked intellectual property firm. Our reputation and strength is a measure of the quality of our people, and we are proud to have the broadest and deepest bench for IP in Canada. With over 100 lawyers, patent agents and trademark agents, we offer legal expertise and technological knowledge across a wide range of industries and scientific and engineering disciplines, with leaders in every field.

Services

Today’s fast-paced innovation economy demands a higher level of expertise and attention to detail when it comes to IP. Our highly skilled team of lawyers, patent agents and trademark agents advise clients on a wide variety of strategic business, brand and technology matters leveraging their deep expertise in intellectual property to help them succeed with IP.

Industries

Across all industries, intellectual property is at the heart of innovation and is key to accelerating business value and growth. Developing a clear IP strategy and knowing how to tap and leverage IP to align with business goals can unlock competitive advantages and make the difference between industry leaders and followers.

Insights

At the forefront of IP in Canada, and actively involved as leaders in industry committees and associations, we stay up-to-date and proactively report on the latest developments in intellectual property law in Canada and around the world. Breaking IP news, changes in the law, important new decisions, and information on key IP issues are provided here through our IP publications and resources.

Careers

Many of the world's most commercially important innovators and most prominent brands trust Smart & Biggar to protect and enforce their IP and to provide them with strategic IP counsel. We have developed a reputation as a firm of talented lawyers and patent and trademark agents with integrity, business savvy and tremendous acumen. That’s why we look for the brightest people with combined talent and strengths in law, business, science and technology.

Who we are

Smart & Biggar is widely recognized as Canada’s leading firm for intellectual property, and with over 100 lawyers, patent agents and trademark agents in five offices, we are also Canada’s largest firm focused purely on IP and related specialty areas.

Commercializing NFTs – generating value from digital assets and intellectual property rights
Generative art NFTs - what brand owners need to know about copyright protection
Stiff penalty for copyright infringer in Canada: Federal Court hands out prison sentence
Branding in the metaverse – how brand owners can find growth in the virtual realm
The marking of trademarks in Canada

View all IP Updates

Patents: Top 5 Most-Read Articles of 2022

Canada’s new patent claim fee rules: Alternative embodiments within a single claim
Canada adopts three-step framework for assessing patentable subject matter in Benjamin Moore
Angelcare and Playtex take out the trash: Diaper Genie patents are valid and infringed by Munchkin
Supreme Court of Canada affirms record-setting $645M patent infringement award in Dow v Nova
Crocs Canada v Double Diamond: Strength of industrial design rights and remedies in Canada reaffirmed by Federal Court

View all IP Updates

Life Sciences: Top 10 Most-Read Articles of 2022

Update on biosimilars in Canada – June 2022
Federal Court holds summary trial appropriate, Apotex and Pharmascience will induce infringement of paliperidone palmitate patent
Merck’s JANUVIA crystalline monohydrate DHP salt patent found valid
Federal Court finds formulation patent relating to ACTONEL DR valid but not infringed
PMPRB update: New regulations now coming into force July 1, 2022
Competition Bureau’s interest in the health sector continues
Federal Court of Appeal upholds validity of glatiramer acetate patent
Confidential rebate reporting and new price regulatory factors of the amended Patented Medicines Regulations declared invalid by the Quebec Court of Appeal
PM(NOC) Regulations: Five-year anniversary of major amendments
Slam dunk! New basket of countries for PMPRB reporting remain, controversial amendments to Patented Medicines Regulations dropped

View all Rx IP Updates

People

Search People

Services

Protect IP

Enforce IP

Grow IP